Plasma concentrations of defensins and lactoferrin in children with severe sepsis
Authors:
- Neal J. ThomasNTNeal J. Thomas
- Joseph A. CarcilloJCJoseph A. Carcillo
- Lesley A. DoughtyLDLesley A. Doughty
- Howell SasserHSHowell Sasser
- R. Phillip HeineRHR. Phillip Heine
- 1 January 2002
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 21 (1) , 34-38
Abstract
We hypothesized that systemic release of endogenous leukocyte-derived polypeptide antimicrobial defensins (polymorphonuclear leukocyte-specific) and lactoferrin (polymorphonuclear leukocyte and epithelial cell derived) occurs in nonneutropenic children with severe sepsis. We performed a prospective cross-sectional and longitudinal study in a university children’s hospital pediatric intensive care unit. Ninety-two consecutive children meeting criteria for sepsis and 14 critically ill children without sepsis (controls) were enrolled, and plasma defensins and lactoferrin concentrations were measured on Days 1 and 3 of sepsis. Nonneutropenic sepsis patients (n = 71) had increased defensins and lactoferrin plasma concentrations compared with critically ill control patients [defensins, 450 ng/ml vs. 150 ng/ml; lactoferrin, 332 ng/ml vs. 176 ng/ml (median values);P < 0.05] and neutropenic sepsis patients [n = 21; defensins, 450 ng/ml vs. 50 ng/ml; lactoferrin, 332 ng/ml vs. 20 ng/ml (median values);P < 0.05]. Neutropenic sepsis patients had similar plasma defensin concentrations and a decrease in plasma lactoferrin concentrations compared with control patients (P < 0.05). Defensins and lactoferrin plasma concentrations correlated to total white blood cell and absolute neutrophil count (P < 0.05). There was no association between plasma defensin concentration and organ failure or outcome; however, increased plasma lactoferrin concentrations were observed with the development of organ failure (P < 0.05). These data suggest that increased circulating defensins and lactoferrin release are dependent in part on neutrophil count and might play a role in host defense in children with severe sepsis.Keywords
This publication has 30 references indexed in Scilit:
- Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trialThe Lancet, 2000
- Elevated Concentrations of Human Neutrophil Peptides in Plasma, Blood, and Body Fluids from Patients with InfectionsClinical Infectious Diseases, 1997
- Plasma bactericidal/permeability-increasing protein concentrations in critically ill children with the sepsis syndromeThe Pediatric Infectious Disease Journal, 1995
- DefensinsCurrent Opinion in Immunology, 1994
- Defensins: a family of antimicrobial and cytotoxic peptidesToxicology, 1994
- Defensins promote fusion and lysis of negatively charged membranesProtein Science, 1993
- Defensins: Antimicrobial and Cytotoxic Peptides of Mammalian CellsAnnual Review of Immunology, 1993
- Human neutrophil peptide defensins induce single strand DNA breaks in target cellsCellular Immunology, 1991
- Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes.Proceedings of the National Academy of Sciences, 1990
- Concurrent assessment of inner and outer membrane permeabilization and bacteriolysis in E. coli by multiple-wavelength spectrophotometryJournal of Immunological Methods, 1988